BRIEF published on 08/15/2025 at 15:20, 7 months 18 days ago Onco-Innovations atteint un taux d'exercice de mandat élevé Financement Non Dilutif Confiance Des Actionnaires Mandats Stratégie De Capital Recherche Sur Le Cancer
BRIEF published on 08/15/2025 at 15:20, 7 months 18 days ago Onco-Innovations Achieves High Warrant Exercise Rate Warrants Non-dilutive Financing Cancer Research Shareholder Confidence Capital Strategy
PRESS RELEASE published on 08/15/2025 at 15:15, 7 months 18 days ago Onco-Innovations Announces 90% of $0.60 Warrants Have Been Exercised Onco-Innovations announces successful execution of key capital strategy with over 90% of outstanding warrants exercised at $0.60, reinforcing investor confidence and internal financing effectiveness Warrants Investor Confidence Capital Strategy Onco-Innovations Internal Financing
BRIEF published on 08/13/2025 at 23:05, 7 months 19 days ago Onco-Innovations clôture un placement privé de 400 000 $ Placement Privé Réglementation Des Valeurs Mobilières Actions Et Bons De Souscription Onco-Innovations Financement Et Développement
BRIEF published on 08/13/2025 at 23:05, 7 months 19 days ago Onco-Innovations Closes $400,000 Private Placement Private Placement Securities Regulation Shares And Warrants Onco-Innovations Funding And Development
PRESS RELEASE published on 08/13/2025 at 23:00, 7 months 19 days ago Onco-Innovations Announces Closing of Private Placement Onco-Innovations Limited announces the closing of a non-brokered private placement, raising $400,000 for general corporate purposes and cancer research. Statutory hold period applies. Not for distribution in the US Non-brokered Private Placement Cancer Research Statutory Hold Period Onco-Innovations Limited Not For Distribution
BRIEF published on 08/04/2025 at 22:10, 7 months 28 days ago Onco-Innovations ouvre la voie aux essais cliniques sur l'homme grâce à un accord clinique avancé Essai Clinique Onco-Innovations Inhibiteur De PNKP Avance Clinique Préparations Réglementaires
BRIEF published on 08/04/2025 at 22:10, 7 months 28 days ago Onco-Innovations Sets Course for Human Trials with Avance Clinical Agreement Clinical Trial Onco-Innovations PNKP Inhibitor Avance Clinical Regulatory Preparations
PRESS RELEASE published on 08/04/2025 at 22:05, 7 months 28 days ago Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement Onco-Innovations partners with Avance Clinical for regulatory and clinical documentation for their PNKP inhibitor therapy. Collaboration aims to advance cancer trials Clinical Trials Cancer Research Onco-Innovations Regulatory Support Avance Clinical
BRIEF published on 07/31/2025 at 00:05, 8 months 2 days ago Inka Health dirigera un projet d'oncologie basé sur l'IA avec OneMedNet Essais Cliniques Données Du Monde Réel Oncologie Innovation En Santé Analyse De L'IA
Published on 04/02/2026 at 15:00, 3 hours 2 minutes ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 3 hours 22 minutes ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 3 hours 32 minutes ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/02/2026 at 14:10, 3 hours 52 minutes ago Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care
Published on 04/02/2026 at 14:00, 4 hours 2 minutes ago Electrovaya Collaborates on U.S. Department of Energy-Funded Project to Advance Energy Storage for Critical Infrastructure
Published on 04/02/2026 at 17:45, 17 minutes ago Minority Shareholders of DKSH Holdings (Malaysia) Berhad Reject Take-Over Offer by DKSH Holding Ltd. at Extraordinary General Meeting
Published on 04/02/2026 at 17:28, 34 minutes ago hep global GmbH recommends approving the jointly agreed, amended resolution proposal of SdK in the voting without a meeting from 12 to 14 April 2026
Published on 04/02/2026 at 16:10, 1 hour 52 minutes ago The Adelaïde Group continued on its growth path in 2025 and consolidated the foundations of its European expansion
Published on 04/02/2026 at 15:32, 2 hours 30 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 04/02/2026 at 17:45, 17 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 04/02/2026 at 17:45, 17 minutes ago Airgas, an Air Liquide company, supplies mission-critical high-pressure nitrogen for NASA’s historic Artemis II launch
Published on 04/02/2026 at 17:45, 17 minutes ago LANSON-BCC : MISE À DISPOSITION DU DOCUMENT D'ENREGISTREMENT UNIVERSEL 2025
Published on 04/02/2026 at 17:45, 17 minutes ago Airgas, filiale du groupe Air Liquide, fournit de l'azote haute pression indispensable pour le lancement historique de la mission Artemis II de la NASA
Published on 04/02/2026 at 17:35, 27 minutes ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
